CDER New August 8, 2016

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

 

August 5, 2016


New and Generic Drug Approvals

August 4, 2016

Drug Name Active Ingredient Dosage Form/Route Sponsor Submission Type
Depo-Subq Provera 104 medroxyprogesterone acetate Injectable;Subcutaneous Pharmacia and Upjohn Manufacturing Change or Addition
Duloxetine Hydrochloride duloxetine hydrochloride Capsule, Delayed Rel Pellets;Oral Hetero Labs Ltd Iii Approval
Fragmin dalteparin sodium Injectable;Injection Pfizer Inc Labeling Revision
Fragmin dalteparin sodium Injectable;Subcutaneous Pfizer Inc Labeling Revision
Kyprolis carfilzomib Powder;Intravenous Onyx Therap Labeling Revision
Pancreaze pancrelipase (amylase;lipase;protease) Capsule, Delayed Release;Oral Janssen Pharms Manufacturing Change or Addition
Sterile Water sterile water for irrigation Liquid;Irrigation Baxter Hlthcare Manufacturing Change or Addition
Zurampic lesinurad Tablet;Oral Ardea Biosciences Manufacturing Change or Addition

 

 

Searching the Orange Book is now faster and easier with our new mobile app!

Download Orange Book Express

 Download iOS App Download Android App Black


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332) Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New August 8, 2016"

Post a Comment